Axsome Therapeutics, Inc. (LON:0HKF)
135.37
+7.14 (5.57%)
Feb 21, 2025, 4:31 PM BST
Axsome Therapeutics Employees
Axsome Therapeutics had 545 employees as of December 31, 2023. The number of employees increased by 162 or 42.30% compared to the previous year.
Employees
545
Change (1Y)
162
Growth (1Y)
42.30%
Revenue / Employee
451.07K GBP
Profits / Employee
-335.90K GBP
Market Cap
5.31B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Axsome Therapeutics News
- 23 days ago - Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader - GlobeNewsWire
- 23 days ago - Axsome gets FDA approval for Symbravo for migraine - Seeking Alpha
- 23 days ago - Axsome Therapeutics Inc (AXSM) Announces FDA Approval of SYMBRAVO for Migraine Treatment - GuruFocus
- 23 days ago - US FDA approves Axsome Therapeutics' migraine drug - Reuters
- 23 days ago - Axsome Therapeutics Announces FDA Approval of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults - GlobeNewsWire
- 5 weeks ago - Axsome Therapeutics expects Q4 and FY24 revenue marginally higher than consensus - Seeking Alpha
- 5 weeks ago - Axsome Therapeutics Inc (AXSM) Reports Strong Preliminary 2024 Revenue Growth - GuruFocus
- 7 weeks ago - Axsome Therapeutics Remains A Buy Despite AXS-05's Mixed Results - Seeking Alpha